21Sep 2023
Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naïve Patients with Helicobacter pylori Infection

Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naïve Patients with Helicobacter pylori Infection

In a recent study, researchers compared the effectiveness of Vonoprazan and Pantoprazole in treating Helicobacter pylori (H. pylori) infection, which can lead to various gastric health issues. The study involved 65 treatment-naïve patients, and it found that both drugs were equally effective in eradicating H. pylori, with success rates of 88.2% and 91.7% for Vonoprazan and Pantoprazole, respectively. Notably, the study noted that adverse events were not significantly different between the two drugs, with no serious adverse events reported. The study highlights the potential of Vonoprazan as a viable treatment option for H. pylori infection.

  • #general medicine

Like

Save

Share